Yingjie Zhang Selected Research

Yingjie Zhang Research Topics

Disease

91	Neoplasms (Cancer) 05/2024 - 07/2004
13	Breast Neoplasms (Breast Cancer) 02/2023 - 04/2011
12	Neoplasm Metastasis (Metastasis) 05/2024 - 08/2011
9	Colonic Neoplasms (Colon Cancer) 12/2023 - 02/2015
9	Carcinoma (Carcinomatosis) 01/2020 - 11/2014
8	Infections 01/2024 - 10/2014
8	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 07/2017
7	Esophageal Neoplasms (Esophageal Cancer) 01/2023 - 01/2017
7	Carcinogenesis 01/2020 - 08/2014
6	Inflammation (Inflammations) 12/2023 - 01/2018
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2023 - 09/2013
5	Esophageal Squamous Cell Carcinoma 01/2023 - 01/2020
5	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 09/2014
5	Body Weight (Weight, Body) 02/2019 - 11/2014
4	Cardiomegaly (Heart Hypertrophy) 03/2024 - 05/2015
4	Fibrosis (Cirrhosis) 12/2023 - 01/2016
4	Myopia 11/2023 - 04/2016
4	Radiation Pneumonitis 01/2023 - 01/2020
4	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 06/2015
4	Leukemia 01/2018 - 08/2014
4	Stomach Neoplasms (Stomach Cancer) 01/2016 - 01/2013
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2023 - 01/2021
3	Multiple Myeloma 10/2023 - 11/2021
3	Reperfusion Injury 05/2023 - 01/2015
3	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 10/2015
3	Heart Failure 01/2023 - 01/2021
3	Autosomal Dominant Polycystic Kidney (ADPKD) 06/2022 - 01/2019
3	Lung Neoplasms (Lung Cancer) 05/2022 - 01/2016
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 08/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 07/2018
3	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2019 - 01/2017
3	Human Influenza (Influenza) 01/2016 - 01/2013
2	Hypertrophy 03/2024 - 05/2015
2	Hypoxia (Hypoxemia) 03/2024 - 07/2021
2	Myocardial Infarction 12/2023 - 01/2021
2	Communicable Diseases (Infectious Diseases) 11/2023 - 11/2022
2	Ischemic Stroke 05/2023 - 01/2023
2	Brain Ischemia (Cerebral Ischemia) 05/2023 - 01/2015
2	Hemorrhage 02/2022 - 01/2020
2	Seroma 05/2021 - 03/2015

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 02/2024 - 08/2008
19	Histone Deacetylase InhibitorsIBA 10/2023 - 01/2008
11	Histone Deacetylases (Histone Deacetylase)IBA 10/2020 - 01/2008
10	Biomarkers (Surrogate Marker)IBA 12/2023 - 07/2016
9	EnzymesIBA 11/2023 - 01/2008
7	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 12/2016
7	Messenger RNA (mRNA)IBA 02/2023 - 05/2015
6	Phosphotransferases (Kinase)IBA 01/2023 - 12/2013
6	Antineoplastic Agents (Antineoplastics)IBA 06/2021 - 08/2014
6	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 02/2015
5	CD13 Antigens (Alanine Aminopeptidase)IBA 06/2021 - 02/2015
5	Vorinostat FDA Link 01/2020 - 04/2011
5	ubenimexIBA 01/2018 - 02/2015
4	CollagenIBA 12/2023 - 01/2016
4	CytokinesIBA 12/2023 - 01/2015
4	Carbon Nanotubes (Carbon Nanotube)IBA 05/2023 - 11/2014
4	Docetaxel (Taxotere)FDA Link 04/2023 - 11/2014
4	MicroRNAs (MicroRNA)IBA 12/2022 - 02/2011
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2022 - 09/2006
4	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2017
4	Lysine (L-Lysine)FDA Link 04/2020 - 11/2014
4	Therapeutic UsesIBA 01/2020 - 02/2015
4	HexokinaseIBA 05/2016 - 09/2014
4	fibroblast growth factor 21IBA 01/2016 - 01/2015
3	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2022
3	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 08/2016
3	Indicators and Reagents (Reagents)IBA 11/2023 - 10/2021
3	HydrogelsIBA 03/2022 - 09/2015
3	MatrinesIBA 09/2019 - 01/2017
3	Adenosine Triphosphate (ATP)IBA 01/2019 - 05/2015
3	Deoxyglucose (2 Deoxy D glucose)IBA 01/2019 - 05/2016
3	Angiogenesis InhibitorsIBA 10/2016 - 11/2013
2	astragaloside AIBA 03/2024 - 01/2019
2	6-methyladenineIBA 12/2023 - 11/2023
2	Long Noncoding RNAIBA 12/2023 - 01/2021
2	Monoclonal AntibodiesIBA 12/2023 - 11/2023
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2023 - 03/2014
2	LipidsIBA 11/2023 - 12/2016
2	ChitosanIBA 05/2023 - 03/2016
2	sintilimabIBA 04/2023 - 12/2022
2	SuspensionsIBA 03/2023 - 01/2022
2	Chloroquine (Aralen)FDA LinkGeneric 01/2023 - 05/2016
2	Protein Isoforms (Isoforms)IBA 01/2023 - 01/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2022 - 11/2014
2	AntibodiesIBA 02/2022 - 06/2015
2	pyrimidineIBA 01/2022 - 11/2021

Therapy/Procedure

37	Therapeutics 12/2023 - 01/2008
17	Radiotherapy 01/2023 - 06/2013
6	Lasers (Laser) 05/2024 - 11/2014
6	Drug Therapy (Chemotherapy) 12/2021 - 01/2015
5	Immunotherapy 05/2024 - 01/2019
4	Transplantation 12/2023 - 01/2016
4	Segmental Mastectomy (Lumpectomy) 05/2021 - 01/2012
3	Oral Administration 05/2023 - 10/2016
3	Neoadjuvant Therapy 01/2023 - 01/2022
3	Photothermal Therapy 06/2017 - 01/2015
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2016 - 01/2013
2	Prostheses and Implants (Prosthesis) 01/2024 - 12/2020
2	Aftercare (After-Treatment) 01/2023 - 05/2017
2	Photochemotherapy (Photodynamic Therapy) 01/2023 - 01/2017